Dr. Gary Kobinger is a regular researcher at the CHU de Québec-Université Laval Research Centre and professor in the Department of Microbiology-Infectious Disease and Immunology. Since 2016, he has managed the Centre de recherche en infectiologie (CRI) at Université Laval. He is also an assistant professor in the Department of Pathology and Laboratory Medicine at the University of Pennsylvania and associate professor at Department of Medical Microbiology at the University of Manitoba.
His work focuses on developing and evaluating new vaccine platforms and immunological treatments against emerging and re-emerging viruses that are dangerous to humans. Dr. Kobinger has received several nominations including the Faculty Teaching Award from the University of Manitoba, the 2014 Gully Award, the 2015 Scientist of the Year Award from ICI Radio-Canada and the Order of Manitoba in 2016. He is known in particular for having co-developed an effective vaccine and treatment against the Ebola virus.
Kobinger will organize the International Society for Vaccines Annual congress (ISV) which will take place at the Québec City Convention Centre in June 2022.
